{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:12:06Z","timestamp":1793391126436,"version":"4.5.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.hrthm.2024.08.064","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T13:00:44Z","timestamp":1725627644000},"page":"1188-1196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Atrial fibrillation and heart failure with preserved ejection fraction \u201ctwindemic\u201d\u2014Shared root causes and treatment targets"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0396-314X","authenticated-orcid":false,"given":"Nicole","family":"Habel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Infeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lustgarten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2024.08.064_bib1","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.08.064_bib2","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hrthm.2024.08.064_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jchf.2017.05.001","article-title":"Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"5","author":"Sartipy","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hrthm.2024.08.064_bib4","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.cardfail.2021.04.015","article-title":"Association between \u03b2-blockers and outcomes in heart failure with preserved ejection fraction: current insights from the SwedeHF Registry","volume":"27","author":"Meyer","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.hrthm.2024.08.064_bib5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jchf.2021.11.006","article-title":"Baseline characteristics of patients with HF with mildly reduced and preserved ejection fraction: DELIVER trial","volume":"10","author":"Solomon","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hrthm.2024.08.064_bib6","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jacbts.2019.05.005","article-title":"Atrial myopathy","volume":"4","author":"Shen","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.hrthm.2024.08.064_bib7","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1093\/eurheartj\/ehac285","article-title":"Post-operative atrial fibrillation and risk of heart failure hospitalization","volume":"43","author":"Goyal","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.08.064_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCULATIONAHA.108.845792","article-title":"The progression of hypertensive heart disease","volume":"123","author":"Drazner","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.08.064_bib9","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jacc.2020.07.009","article-title":"Atrial dysfunction in patients with heart failure with preserved ejection fraction and atrial fibrillation","volume":"76","author":"Reddy","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib10","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1161\/CIRCULATIONAHA.106.632745","article-title":"Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction","volume":"114","author":"Borlaug","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.08.064_bib11","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","article-title":"Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms","volume":"116","author":"Hall","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2024.08.064_bib12","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jacc.2010.10.042","article-title":"Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort","volume":"57","author":"Russo","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006662","article-title":"Impact of atrial fibrillation on exercise capacity and mortality in heart failure with preserved ejection fraction: insights from cardiopulmonary stress testing","volume":"6","author":"Elshazly","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2024.08.064_bib14","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/HYPERTENSIONAHA.118.11125","article-title":"Myocardial remodeling in hypertension","volume":"72","author":"Gonzalez","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.hrthm.2024.08.064_bib15","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Group","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2024.08.064_bib17","article-title":"Lower heart rates and beta-blockers are associated with new-onset atrial fibrillation","volume":"17","author":"Habel","year":"2023","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"10.1016\/j.hrthm.2024.08.064_bib18","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1161\/HYPERTENSIONAHA.120.14766","article-title":"Effect of intensive blood pressure lowering on the risk of atrial fibrillation","volume":"75","author":"Soliman","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.hrthm.2024.08.064_bib19","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1161\/CIRCULATIONAHA.108.830042","article-title":"Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women","volume":"119","author":"Conen","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.08.064_bib20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction","volume":"138","author":"Reddy","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.08.064_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2024.08.064_bib22","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2024.08.064_bib23","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2024.08.064_bib24","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2024.08.064_bib25","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2301972","article-title":"Triple-hormone-receptor agonist retatrutide for obesity\u2014a phase 2 trial","volume":"389","author":"Jastreboff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2024.08.064_bib26","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2024.08.064_bib27","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.jacc.2010.02.029","article-title":"The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (Women\u2019s Health Study)","volume":"55","author":"Tedrow","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijcard.2017.03.103","article-title":"Atrial fibrillation risk in metabolically healthy obesity: a nationwide population-based study","volume":"240","author":"Lee","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib29","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib30","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/jamacardio.2018.0095","article-title":"Associations of obstructive sleep apnea with atrial fibrillation and continuous positive airway pressure treatment: a review","volume":"3","author":"Linz","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib31","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.283.14.1829","article-title":"Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: Sleep Heart Health Study","volume":"283","author":"Nieto","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2024.08.064_bib32","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200005113421901","article-title":"Prospective study of the association between sleep-disordered breathing and hypertension","volume":"342","author":"Peppard","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2024.08.064_bib33","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.ehj.2004.04.017","article-title":"Severe bradyarrhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatment: a long-term evaluation using an insertable loop recorder","volume":"25","author":"Simantirakis","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.08.064_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.hrthm.2024.08.064_bib35","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/j.jacc.2008.09.014","article-title":"The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study","volume":"52","author":"Bluemke","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib36","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005379","article-title":"Left atrial structure in relationship to age, sex, ethnicity, and cardiovascular risk factors: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"10","author":"Zemrak","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2024.08.064_bib37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/CIRCIMAGING.108.819938","article-title":"Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the Multi-Ethnic Study of Atherosclerosis","volume":"2","author":"Cheng","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2024.08.064_bib38","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jacc.2022.07.011","article-title":"Heart Failure With Preserved Ejection Fraction as an Exercise Deficiency Syndrome: JACC Focus Seminar 2\/4","volume":"80","author":"La","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib39","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.2023.2020","article-title":"Heart failure with preserved ejection fraction: a review","volume":"329","author":"Redfield","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2024.08.064_bib40","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.jacc.2023.09.821","article-title":"Changes in pulmonary artery pressure late in life: the Atherosclerosis Risk in Communities (ARIC) study","volume":"82","author":"Zierath","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib41","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jchf.2016.10.012","article-title":"The influence of age on hemodynamic parameters during rest and exercise in healthy individuals","volume":"5","author":"Wolsk","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hrthm.2024.08.064_bib42","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijcard.2013.12.009","article-title":"Atrial fibrillation: a progressive atrial myopathy or a distinct disease?","volume":"171","author":"Kallergis","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib43","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.jacc.2014.02.555","article-title":"Atrial remodeling and atrial fibrillation: recent advances and translational perspectives","volume":"63","author":"Nattel","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib44","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41569-020-0363-2","article-title":"Evaluation and management of heart failure with preserved ejection fraction","volume":"17","author":"Borlaug","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib45","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/CIRCHEARTFAILURE.109.930701","article-title":"Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction","volume":"3","author":"Borlaug","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hrthm.2024.08.064_bib46","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/CIRCULATIONAHA.121.054117","article-title":"One-year committed exercise training reverses abnormal left ventricular myocardial stiffness in patients with stage B heart failure with preserved ejection fraction","volume":"144","author":"Hieda","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.08.064_bib47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1179\/2045772313Y.0000000161","article-title":"Structural and functional left ventricular impairment in subjects with chronic spinal cord injury and no overt cardiovascular disease","volume":"37","author":"Driussi","year":"2014","journal-title":"J Spinal Cord Med"},{"key":"10.1016\/j.hrthm.2024.08.064_bib48","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.hrthm.2015.10.021","article-title":"Spinal cord injury is associated with an increased risk of atrial fibrillation: a population-based cohort study","volume":"13","author":"Wang","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.08.064_bib49","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1152\/jappl.2001.91.2.645","article-title":"Cardiac atrophy after bed rest and spaceflight","volume":"91","author":"Perhonen","year":"2001","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.hrthm.2024.08.064_bib50","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/heartjnl-2013-305304","article-title":"Atrial fibrillation is associated with different levels of physical activity levels at different ages in men","volume":"100","author":"Drca","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2024.08.064_bib51","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1136\/heartjnl-2014-307145","article-title":"Physical activity is associated with a reduced risk of atrial fibrillation in middle-aged and elderly women","volume":"101","author":"Drca","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2024.08.064_bib52","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12872-022-02643-4","article-title":"Association of physical activity with the incidence of atrial fibrillation in persons >65 years old: the Atherosclerosis Risk in Communities (ARIC) study","volume":"22","author":"Fletcher","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.hrthm.2024.08.064_bib53","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1177\/2047487318768026","article-title":"Physical activity volume in relation to risk of atrial fibrillation: a non-linear meta-regression analysis","volume":"25","author":"Ricci","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib54","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/CIRCULATIONAHA.115.018220","article-title":"Aerobic interval training reduces the burden of atrial fibrillation in the short term: a randomized trial","volume":"133","author":"Malmo","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.08.064_bib55","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2015.06.488","article-title":"Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT study","volume":"66","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib56","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1093\/eurheartj\/ehy268","article-title":"Haemodynamics, dyspnoea, and pulmonary reserve in heart failure with preserved ejection fraction","volume":"39","author":"Obokata","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.08.064_bib57","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1161\/01.CIR.92.9.2764","article-title":"Guidelines for the evaluation and management of heart failure: report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)","volume":"92","author":"Williams","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.08.064_bib58","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jacc.2004.10.068","article-title":"Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study","volume":"45","author":"Wachtell","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib59","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jacc.2008.05.057","article-title":"Beta-blockers for primary prevention of heart failure in patients with hypertension insights from a meta-analysis","volume":"52","author":"Bangalore","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib60","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.amjmed.2014.05.032","article-title":"Clinical outcomes with \u03b2-blockers for myocardial infarction: a meta-analysis of randomized trials","volume":"127","author":"Bangalore","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.hrthm.2024.08.064_bib61","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006213","article-title":"Heart rate and heart failure with preserved ejection fraction: time to slow \u03b2-blocker use?","volume":"12","author":"Meyer","year":"2019","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hrthm.2024.08.064_bib62","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.16598","article-title":"Association of \u03b2-blocker use with heart failure hospitalizations and cardiovascular disease mortality among patients with heart failure with a preserved ejection fraction: a secondary analysis of the TOPCAT trial","volume":"2","author":"Silverman","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hrthm.2024.08.064_bib63","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/europace\/euad010","article-title":"Beta-blockers in atrial fibrillation\u2014trying to make sense of unsettling results","volume":"25","author":"Meyer","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2024.08.064_bib64","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahlof","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2024.08.064_bib65","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa1406430","article-title":"Ivabradine in stable coronary artery disease without clinical heart failure","volume":"371","author":"Fox","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2024.08.064_bib66","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/eurheartj\/eht429","article-title":"Calcium channel blockers improve exercise capacity and reduce N-terminal pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation","volume":"35","author":"Ulimoen","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.08.064_bib67","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/clc.4960240112","article-title":"Heart rate-lowering and -regulating effects of once-daily sustained-release diltiazem","volume":"24","author":"Boden","year":"2001","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib68","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10741-017-9660-1","article-title":"Pharmacological heart rate lowering in patients with a preserved ejection fraction\u2014review of a failing concept","volume":"23","author":"Meyer","year":"2018","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.hrthm.2024.08.064_bib69","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/jamacardio.2023.5500","article-title":"\u03b2-Blocker withdrawal and functional capacity improvement in patients with heart failure with preserved ejection fraction","volume":"9","author":"Palau","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib70","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.jacc.2021.08.073","article-title":"Effect of \u03b2-blocker withdrawal on functional capacity in heart failure and preserved ejection fraction","volume":"78","author":"Palau","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib71","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1093\/eurheartj\/ehp341","article-title":"Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure","volume":"30","author":"Wachter","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.08.064_bib72","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.107.716886","article-title":"Role of left ventricular stiffness in heart failure with normal ejection fraction","volume":"117","author":"Westermann","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.08.064_bib73","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017215","article-title":"Heart rate-induced myocardial Ca2+ retention and left ventricular volume loss in patients with heart failure with preserved ejection fraction","volume":"9","author":"Silverman","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2024.08.064_bib74","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.hroo.2020.09.004","article-title":"An approach towards individualized lower rate settings for pacemakers","volume":"1","author":"Infeld","year":"2020","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.hrthm.2024.08.064_bib75","doi-asserted-by":"crossref","first-page":"H1031","DOI":"10.1152\/ajpheart.00301.2016","article-title":"Heart rate-induced modifications of concentric left ventricular hypertrophy: exploration of a novel therapeutic concept","volume":"311","author":"Klein","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib76","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jacc.2010.10.069","article-title":"Tachycardia-induced diastolic dysfunction and resting tone in myocardium from patients with a normal ejection fraction","volume":"58","author":"Selby","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib77","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.011307","article-title":"Diastolic tone\u2014friend and foe of cardiac performance","volume":"16","author":"Meyer","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hrthm.2024.08.064_bib78","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/CIRCULATIONAHA.121.056412","article-title":"A targeted treatment opportunity for HFpEF: taking advantage of diastolic tone","volume":"144","author":"Meyer","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.08.064_bib79","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004311","article-title":"Relaxation and the role of calcium in isolated contracting myocardium from patients with hypertensive heart disease and heart failure with preserved ejection fraction","volume":"10","author":"Runte","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hrthm.2024.08.064_bib80","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa032566","article-title":"Diastolic heart failure\u2014abnormalities in active relaxation and passive stiffness of the left ventricle","volume":"350","author":"Zile","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2024.08.064_bib81","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12933-016-0490-6","article-title":"Differential effects of glucagon-like peptide-1 receptor agonists on heart rate","volume":"16","author":"Lorenz","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib82","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/hh1701.095716","article-title":"Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes","volume":"89","author":"Vila Petroff","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2024.08.064_bib83","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/00005344-199804000-00010","article-title":"Chronotropic effects of cilostazol, a new antithrombotic agent, in patients with bradyarrhythmias","volume":"31","author":"Atarashi","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib84","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jchf.2021.01.015","article-title":"Levosimendan improves hemodynamics and exercise tolerance in PH-HFpEF: results of the randomized placebo-controlled HELP trial","volume":"9","author":"Burkhoff","year":"2021","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hrthm.2024.08.064_bib85","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.jacc.2016.03.539","article-title":"Effects of milrinone on rest and exercise hemodynamics in heart failure with preserved ejection fraction","volume":"67","author":"Kaye","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib86","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1054\/JCPT.2000.8696","article-title":"Effects of cilostazol on heart rate and its variation in patients with atrial fibrillation associated with bradycardia","volume":"5","author":"Toyonaga","year":"2000","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.hrthm.2024.08.064_bib87","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0735-1097(96)00592-X","article-title":"Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies","volume":"29","author":"Shinbane","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib88","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2024.08.064_bib89","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.HYP.0000121223.44837.de","article-title":"Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients","volume":"43","author":"Muiesan","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.hrthm.2024.08.064_bib90","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1056\/NEJMra072139","article-title":"Cardiac plasticity","volume":"358","author":"Hill","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2024.08.064_bib91","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.010395","article-title":"Left ventricular gene expression in heart failure with preserved ejection fraction\u2014profibrotic and proinflammatory pathways and genes","volume":"16","author":"Ye","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hrthm.2024.08.064_bib92","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032873","article-title":"Effects of continuous accelerated pacing on cardiac structure and function in patients with heart failure with preserved ejection fraction: insights from the myPACE randomized clinical trial","volume":"13","author":"Wahlberg","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2024.08.064_bib93","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1001\/jama.2023.7946","article-title":"Rate-adaptive atrial pacing for heart failure with preserved ejection fraction\u2014reply","volume":"329","author":"Reddy","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2024.08.064_bib94","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0140-6736(22)00016-2","article-title":"Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial","volume":"399","author":"Shah","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2024.08.064_bib95","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.hroo.2023.12.001","article-title":"Rationale and design of the PACE HFpEF trial: physiologic accelerated pacing as a holistic treatment of heart failure with preserved ejection fraction","volume":"5","author":"Habel","year":"2023","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.hrthm.2024.08.064_bib96","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.hroo.2021.11.015","article-title":"Personalized pacing for diastolic dysfunction and heart failure with preserved ejection fraction: design and rationale for the myPACE randomized controlled trial","volume":"3","author":"Infeld","year":"2022","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.hrthm.2024.08.064_bib97","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.amjcard.2019.07.008","article-title":"Effects of a higher heart rate on quality of life and functional capacity in patients with left ventricular diastolic dysfunction","volume":"124","author":"Wahlberg","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib98","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cardfail.2018.06.009","article-title":"Safety and feasibility of a nocturnal heart rate elevation\u2014exploration of a novel treatment concept","volume":"25","author":"Yeshwant","year":"2019","journal-title":"J Card Fail"},{"key":"10.1016\/j.hrthm.2024.08.064_bib99","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.hrthm.2024.03.1786","article-title":"Bachmann bundle pacing","volume":"21","author":"Lustgarten","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.08.064_bib100","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/jamacardio.2022.5320","article-title":"Effect of personalized accelerated pacing on quality of life, physical activity, and atrial fibrillation in patients with preclinical and overt heart failure with preserved ejection fraction: the myPACE randomized clinical trial","volume":"8","author":"Infeld","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrthm.2024.08.064_bib101","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2023.0675","article-title":"Rate-adaptive atrial pacing for heart failure with preserved ejection fraction: the RAPID-HF randomized clinical trial","volume":"329","author":"Reddy","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2024.08.064_bib102","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2024.08.064_bib103","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10741-013-9394-7","article-title":"Assessing health-related quality of life in patients with heart failure: a systematic, standardized comparison of available measures","volume":"19","author":"Garin","year":"2014","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.hrthm.2024.08.064_bib104","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cardfail.2009.08.010","article-title":"Patients\u2019 self-assessed functional status in heart failure by New York Heart Association class: a prognostic predictor of hospitalizations, quality of life and death","volume":"16","author":"Holland","year":"2010","journal-title":"J Card Fail"},{"key":"10.1016\/j.hrthm.2024.08.064_bib105","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1253\/circj.CJ-10-1308","article-title":"Quality of life as an independent predictor for cardiac events and death in patients with heart failure","volume":"75","author":"Kato","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.hrthm.2024.08.064_bib107","series-title":"Poster presented at: American Heart Association Meeting; November 11-13","article-title":"Effects of continuous accelerated pacing on clinical outcomes in patients with heart failure with preserved ejection fraction: three year follow up of the myPACE randomized clinical trial","author":"Infeld M","year":"2023"},{"key":"10.1016\/j.hrthm.2024.08.064_bib108","series-title":"Poster presented at: Heart Rhythm Society Meeting, May 17-19","article-title":"Physiologic accelerated pacing as a treatment for heart failure with preserved ejection fraction","author":"Habel","year":"2024"},{"key":"10.1016\/j.hrthm.2024.08.064_bib109","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jchf.2021.05.020","article-title":"Pulmonary artery pressure monitoring effectively guides management to reduce heart failure hospitalizations in obesity","volume":"9","author":"Brinkley","year":"2021","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hrthm.2024.08.064_bib110","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial","volume":"377","author":"Abraham","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2024.08.064_bib111","doi-asserted-by":"crossref","first-page":"G33","DOI":"10.1093\/eurheartjsupp\/suad117","article-title":"Personalized accelerated physiologic pacing","volume":"25","author":"Meyer","year":"2023","journal-title":"Eur Heart J Suppl"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527124032909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527124032909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:20:42Z","timestamp":1762550442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527124032909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":109,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1547527124032909"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.08.064","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial fibrillation and heart failure with preserved ejection fraction \u201ctwindemic\u201d\u2014Shared root causes and treatment targets","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.08.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Heart Rhythm Society. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}